The Oral, Live Attenuated Enterotoxigenic Escherichia coli Vaccine ACE527 Reduces the Incidence and Severity of Diarrhea in a Human Challenge Model of Diarrheal Disease

A Combination Vaccine Consisting of Three Live Attenuated Enterotoxigenic Escherichia coli Strains Expressing a Range of Colonization Factors and Heat-Labile Toxin Subunit B Is Well Tolerated and Immunogenic in a Placebo-Controlled Double-Blind Phase I Trial in Healthy Adults

(2011) Clayton Harro et al.   Clinical and Vaccine Immunology

Refinement of a Human Challenge Model for Evaluation of Enterotoxigenic Escherichia coli Vaccines

(2011) Clayton Harro et al.   Clinical and Vaccine Immunology

A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC)

(2011) Chad K. Porter et al.   VACCINE

Prolonged Episodes of Acute Diarrhea Reduce Growth and Increase Risk of Persistent Diarrhea in Children

(2010) Sean R. Moore et al.   GASTROENTEROLOGY

Global, regional, and national causes of child mortality in 2008: a systematic analysis

(2010) Robert E Black et al.   LANCET

Estimating child mortality due to diarrhoea in developing countries

(2008) Cynthia Boschi-Pinto   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Enteric infections, diarrhea, and their impact on function and development

(2008) William A. Petri et al.   JOURNAL OF CLINICAL INVESTIGATION

Economic Aspects of Travelers’ Diarrhea

(2008) Mathyas Wang et al.   JOURNAL OF TRAVEL MEDICINE

Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial

(2008) Sarah A Frech et al.   LANCET

A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC

(2008) Robin McKenzie et al.   VACCINE